Astrotech (ASTC) AI Stock Analysis

• Market Cap: $10.08M
• Dividend Yield: N/A
• Average Volume (3M): 2.80K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.54
• Revenue Growth: -54.94%
• EPS Growth: -24.76%
• Country: US
• Employees: 30
• Sector: Industrials
• Sector Strength: 90
• Industry: Aerospace & Defense
• EPS (TTM): -2.18
• Shares Outstanding: 1,693,953
• 10 Day Avg. Volume: 2,977
• 30 Day Avg. Volume: 2,800
• PEG Ratio: 0.23
• Price to Book (P/B): 0.39
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -0.72
• Enterprise Value/Market Cap: 0.72
• Enterprise Value/Revenue: 1.71
• Enterprise Value/Gross Profit: 16.97
• Enterprise Value/Ebitda: -0.14
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: $5.50 ▼( -7.56% Downside)

Astrotech's overall stock score is primarily impacted by its weak financial performance and valuation metrics, which highlight ongoing operational and profitability challenges. Technical analysis suggests a bearish trend, further weighing on the stock's prospects. Despite a positive corporate event, the lack of immediate financial impact keeps the overall score low.

Astrotech Business Overview & Revenue Model

Company Description

Astrotech (ASTC) is a technology company that operates in the aerospace and industrial sectors. It is primarily engaged in developing and commercializing technological solutions that address critical challenges in space, defense, and industrial markets. Its core products and services include mass spectrometry technology, advanced chemical detection, and analytical instrumentation for various applications.

How the Company Makes Money

Astrotech generates revenue through the sale and licensing of its technological products and services. The company focuses on the commercialization of its proprietary technologies, which are often developed for niche markets within the aerospace and defense industries. Key revenue streams include the sale of mass spectrometry equipment and related services, licensing agreements for its technology, and government contracts for research and development. Significant partnerships with industry leaders and government agencies also contribute to its earnings, facilitating the adoption and integration of its solutions into broader market applications.

Astrotech Financial Statement Overview

Summary

Astrotech faces substantial financial challenges characterized by declining revenues, persistent losses, and negative cash flows. While the balance sheet shows a strong equity position and minimal debt, the company struggles with profitability and operational efficiency. The combination of these factors suggests that Astrotech needs to address its revenue growth and cost management to improve its financial health and viability.

Income Statement

Astrotech's revenue has shown inconsistency with a notable decrease in the most recent TTM (Trailing-Twelve-Months) period. Gross profit margin is relatively healthy at 47.5%, indicating effective cost management. However, the company is facing significant challenges with profitability, as evidenced by a negative net profit margin of -1537.1% and negative EBIT and EBITDA margins. The lack of revenue growth and persistent losses highlight significant financial difficulties.

Balance Sheet

Astrotech maintains a strong equity base with an equity ratio of 90.0%, indicating a low reliance on debt. The debt-to-equity ratio stands at a very low 0.005, suggesting minimal financial leverage. However, the company’s return on equity is negative due to ongoing losses, which undermines the potential benefits of its strong equity position.

Cash Flow

The company is experiencing negative free cash flow, with a significant decline in operating cash flow to net income ratio, indicating operational inefficiencies. Free cash flow growth rate is negative, reflecting ongoing cash burn issues. Despite a positive trend in investing cash flow, the overall cash flow situation remains concerning, impacting the company’s ability to sustain operations without external financing.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
903.00K	1.66M	750.00K	869.00K	334.00K	488.00K
	Gross Profit
429.00K	751.00K	306.00K	192.00K	36.00K	39.00K
	EBIT
-15.16M	-13.28M	-11.06M	-8.60M	-7.40M	-8.11M
	EBITDA
-14.36M	-12.55M	-10.69M	-8.36M	-7.31M	-7.58M
	Net Income Common Stockholders
-13.88M	-11.67M	-9.64M	-7.56M	-7.61M	-8.51M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
20.87M	31.92M	42.13M	52.63M	63.29M	3.35M
	Total Assets
27.49M	37.64M	47.67M	56.22M	65.63M	5.93M
	Total Debt
121.00K	300.00K	607.00K	1.04M	2.80M	4.00M
	Net Debt
-2.69M	-10.14M	-13.60M	-25.42M	-33.14M	655.00K
	Total Liabilities
2.74M	2.83M	2.96M	2.98M	4.43M	5.30M
	Stockholders Equity
24.75M	34.81M	44.72M	53.24M	61.21M	625.00K
Cash Flow		Free Cash Flow
-13.79M	-10.30M	-9.47M	-7.39M	-7.62M	-6.93M
	Operating Cash Flow
-13.08M	-9.72M	-7.63M	-6.79M	-7.41M	-6.93M
	Investing Cash Flow
7.61M	6.14M	-3.84M	-596.00K	-27.59M	0.00
	Financing Cash Flow
-202.00K	-181.00K	-776.00K	-2.10M	67.58M	8.69M

Astrotech Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 5.95
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASTC, the sentiment is Neutral. The current price of 5.95 is above the 20-day moving average (MA) of 5.89, below the 50-day MA of 6.09, and below the 200-day MA of 7.25, indicating a neutral trend. The MACD of -0.04 indicates Negative momentum. The RSI at 50.17 is Neutral, neither overbought nor oversold. The STOCH value of 40.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ASTC.

Astrotech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	64 Neutral	$4.39B	11.81	5.17%	249.38%	3.98%	-12.17%
XTIA	53 Neutral	$11.69M	―	-327.59%	―	―	―
PRZO	47 Neutral	$14.79M	―	-370.62%	―	49.04%	-121.30%
ASTC	41 Neutral	$10.08M	―	-44.54%	―	-54.94%	-24.76%
MNTS	38 Underperform	$8.97M	―	688.16%	―	-46.28%	93.33%
SIDU	37 Underperform	$27.82M	―	-109.05%	―	-18.70%	84.35%

Astrotech Corporate Events

Astrotech Launches Enhanced TRACER 1000 Narcotics Detector

On March 10, 2025, Astrotech Corporation announced the launch of the enhanced TRACER 1000™ Narcotics Trace Detector from its 1st Detect subsidiary. This advanced mass spectrometer is designed to detect synthetic opiates and novel psychoactive substances, offering a significant improvement in portable trace detection. The TRACER 1000 NTD aims to aid law enforcement, border security, and public health agencies in addressing the global synthetic drug crisis by providing rapid and precise identification of illicit substances. The device’s enhanced capabilities could help authorities prevent dangerous drugs from reaching communities, thus positioning Astrotech as a key player in the fight against synthetic drug trafficking.